allpack group ag: Advancing Sustainable Pharmaceutical Packaging

Main image credit: 

allpack group ag, a leading company in the pharmaceutical packaging industry, is known for its innovative packaging solutions and dedication to high-quality standards, advancing sustainable pharmaceutical packaging, offering solutions that prioritize environmental responsibility alongside patient safety and packaging efficiency. 

Recently, the company has become a member of the newly formed Rhenopharma Group, an alliance of premier companies in the pharmaceutical sector. This new coalition, which also includes Rhenochem AG and Konapharma AG is committed to advancing the development, manufacturing and distribution of top-tier pharmaceutical products and services.  

The Rhenopharma Group emphasizes quality, agility, and sustainability, integrating eco-friendly practices and resource-efficient technologies into its operations. By pooling their expertise, the group aims to enhance healthcare outcomes and contribute to a more sustainable future, marking a significant step forward in the industry. 

The pharmaceutical industry is evolving rapidly, with sustainability playing an increasingly vital role in packaging decisions. This shift is driven by stringent environmental regulations, the need for cost-effective solutions, and the demand for patient-friendly packaging. allpack group ag is committed to addressing these challenges through its focus on sustainability and innovation.

Contract Packaging Organizations (CPOs) like allpack group ag are crucial in the pharmaceutical supply chain. They offer specialized expertise and flexibility, allowing pharmaceutical companies to concentrate on core activities while ensuring that packaging meets high standards of safety, efficacy, and sustainability. 

Outsourcing packaging operations can greatly enhance sustainability efforts by providing pharmaceutical companies with access to specialized expertise and resources. This collaboration allows for the adoption of more eco-friendly practices and materials, helping companies reduce their environmental footprint more effectively. 

Sustainable pharmaceutical packaging involves multiple layers, from primary packaging that directly contacts the drug to secondary and tertiary packaging used in handling and transportation. Each layer presents unique challenges and opportunities for innovation. 

One focus area is the development of eco-friendly blister packs. While recycled materials are not used in primary pharmaceutical packaging due to strict regulatory standards, there are opportunities to improve sustainability. For instance, substituting PVC blisters with other polymers (e.g. PP) can contribute to a circular economy (Mono-blisters). While these materials are recyclable, they often have low, some medium barrier performance. Ultra-high barrier recyclable pharma packaging materials are not yet available in the market. 

Recycling plastics to create new products instead of relying on fossil resources conserves natural resources, saves energy, reduces greenhouse gas emissions, and helps keep plastic waste out of the environment. 

These advancements are particularly important as some markets consider banning PVC altogether.

Collaboration is crucial in achieving sustainability goals in the pharmaceutical industry. allpack group ag partners with pharmaceutical companies, its partners along the supply chain, and other stakeholders to align sustainability efforts across the supply chain. 

These partnerships focus on meeting regulatory requirements and fostering a culture of sustainability within the industry. Achieving the "Triple Bottom Line" of People, Planet, and Profit requires dedicated collaboration and alignment of goals from all players involved in the pharmaceutical pipeline.

Despite advancements, transitioning to sustainable pharmaceutical packaging presents challenges. Regulatory requirements, eventually higher costs, and the need for patient-friendly solutions are significant hurdles.  

For example, while eco-friendly secondary packaging materials like paper and cardboard are less of a circular economic challenge, they must still fulfil essential roles such as protection of primary packaging, regulatory compliance, tamper evidence, and patient education without compromising the overall quality and safety of the medication. 

Patient-centric packaging is also increasingly important. Patients demand packaging that is easy to use, child-resistant, and senior-friendly, adding another layer of complexity to the design and manufacturing process. Innovations like smart packaging, which can track medication usage and provide interactive information through QR codes, are being developed to address these needs. 

allpack group ag exemplifies the balance between innovation, sustainability, and practicality in pharmaceutical packaging. By leveraging advanced technologies and fostering strong industry partnerships, allpack group ag is helping to drive the pharmaceutical industry towards a more sustainable future.

As the industry continues to evolve, the role of CPOs will be increasingly vital in meeting the dual challenges of sustainability and patient safety.

In summary, allpack group ag 's commitment to sustainable practices, combined with its innovative approach, positions it as a key player in the pharmaceutical packaging sector. The company's efforts are paving the way for a more sustainable and efficient future in pharmaceutical packaging, ensuring that the industry can meet both current and future challenges.